David J. Lockhart
2010
In 2010, David J. Lockhart earned a total compensation of $599.6K as Chief Scientific Officer at Amicus Therapeutics, a 44% decrease compared to previous year.
Compensation breakdown
| Bonus | $159,586 |
|---|---|
| Option Awards | $59,512 |
| Salary | $367,710 |
| Other | $12,790 |
| Total | $599,598 |
Lockhart received $367.7K in salary, accounting for 61% of the total pay in 2010.
Lockhart also received $159.6K in bonus, $59.5K in option awards and $12.8K in other compensation.
Rankings
In 2010, David J. Lockhart's compensation ranked 7,105th out of 10,439 executives tracked by ExecPay. In other words, Lockhart earned more than 31.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 7,105 out of 10,439 | 32nd |
Division Manufacturing | 2,600 out of 3,838 | 32nd |
Major group Chemicals And Allied Products | 611 out of 921 | 34th |
Industry group Drugs | 410 out of 680 | 40th |
Industry Pharmaceutical Preparations | 310 out of 481 | 36th |
Source: SEC filing on April 26, 2013.
Lockhart's colleagues
We found five more compensation records of executives who worked with David J. Lockhart at Amicus Therapeutics in 2010.
2010
John Crowley
Amicus Therapeutics
Chief Executive Officer
2010
Matthew Patterson
Amicus Therapeutics
Former President
2010
Pol Boudes
Amicus Therapeutics
Chief Medical Officer
2010
Mohan Ganesan
Amicus Therapeutics
Former Principal Financial Officer
2010
John McAdam
Amicus Therapeutics